Anthem, Cigna Face Off Against U.S. to Save $48 Billion Deal

  • U.S. antitrust enforcers say merger will raise consumer costs
  • Washington showdown precedes Aetna-Humana trial in December
Photographer: Andrew Harrer/Bloomberg
Lock
This article is for subscribers only.

Anthem Inc., Cigna Corp. and the U.S. government offered a federal judge very different views of the impact their proposed $48 billion combination will have on health-insurance markets.

A Justice Department lawyer said Monday at the start of an antitrust trial in Washington that the biggest merger in the history of the American health-insurance industry should be blocked because it will increase the companies’ dominance and cut consumer choice.